SCHEMBL4879748

SCHEMBL4879748

O=c1c(O)c(-c2ccc(O)c(O)c2)oc2ccc(O)c(O)c12

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AMY1A P0DUB6 3/20 0.78
PIM1 P11309 2/20 0.78
CD38 P28907 2/20 0.78
MEN1 O00255 8/20 0.71
KMT2A Q03164 8/20 0.71
KDM4E B2RXH2 7/20 0.71
ALOX15 P16050 6/20 0.71
CYP3A4 P08684 6/20 0.71
HSD17B10 Q99714 6/20 0.71
MAPT P10636 6/20 0.71
RECQL P46063 5/20 0.71
TP53 P04637 5/20 0.71
CYP2C9 P11712 5/20 0.71
BCL9 O00512 5/20 0.71
CTNNB1 P35222 5/20 0.71
SLCO2B1 O94956 4/20 0.71
ALDH1A1 P00352 4/20 0.71
HPGD P15428 4/20 0.71
LMNA P02545 4/20 0.71
APP P05067 4/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Quercetagetin SCHEMBL554527 0.88 AMY1A (1.00) AMY1APIM1CD38MEN1KMT2A
Quercetagetin SCHEMBL29690479 0.88 AMY1A (1.00) AMY1APIM1CD38MEN1KMT2A
Quercetagetin SCHEMBL29608135 0.88 AMY1A (1.00) AMY1APIM1CD38MEN1KMT2A
SCHEMBL31022147 0.86 AMY1A (0.81) AMY1APIM1CD38MEN1KMT2A
SCHEMBL20798544 0.85 MEN1 (0.68) AMY1APIM1CD38MEN1KMT2A
SCHEMBL18676308 0.84 MEN1 (0.72) AMY1APIM1CD38MEN1KMT2A
SCHEMBL29826664 0.84 MEN1 (0.72) AMY1APIM1CD38MEN1KMT2A
SCHEMBL31326068 0.84 MEN1 (0.72) AMY1APIM1CD38MEN1KMT2A
SCHEMBL12557418 0.84 AMY1A (0.77) AMY1APIM1CD38MEN1KMT2A
SCHEMBL32691250 0.84 AMY1A (0.77) AMY1APIM1CD38MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240085670-A1 METHODS OF MAKING A LOW-COST MINIATURE ACCOMMODATING OPTICAL IMAGING SYSTEM NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2024-03-14 US claimed
CN-102639126-B Pterostilbene (PTER) for use in the prevention and/or treatment of skin diseases, damages or injuries 绿色分子有限公司 2018-07-06 CN claimed
EP-1829447-B1 AQUEOUS COMPOSITION FOR THE PROTECTION AND STRENGTHENING OF PLANTS AND APPLICATION METHOD THEREOF CT DE INVESTIGACION Y ASISTENCIA EN TECNOLOGIA Y DISENO DEL ESTADO DE JALISCO A C CIATEJ A C (MX) 2012-08-15 EP claimed
US-8084396-B2 Polyethylene glycol, vitamin A, red coloring agent; preventing biotic or abiotic factors generating stress in plants Centro de Investigacion y Asistencia en Technologia y Diseno del Estado de Jalisco A.C. (MX) 2011-12-27 US claimed
US-20080119360-A1 Aqueous Composition for the Protection and Strengthening of Plants and Application Method Thereof CENTRO DE INVESTIGACION Y ASISTENCIA (MX) 2008-05-22 US claimed
EP-1829447-A1 AQUEOUS COMPOSITION FOR THE PROTECTION AND STRENGTHENING OF PLANTS AND APPLICATION METHOD THEREOF Centro de Investigacion y Asistencia en Technologa y Diseo del Estado de Jalisco, A.C. ( Ciatej, A.C.) (MX) 2007-09-05 EP claimed
US-20250295791-A1 COLLAGEN-CONTAINING CURABLE FORMULATIONS COLLPLANT LTD. (IL) 2025-09-25 US disclosed
EP-4587329-A1 MULTIPLE-COMPONENT COATING KIT AND METHOD OF USE THEREOF TO IMPART ANTI-ICING CHARACTERISTICS TO ARTICLES Phazebreak Coatings, Inc. (US) 2025-07-23 EP disclosed
CN-120037228-A Application of quercetin in resisting silkworm nuclear polyhedrosis virus 华南农业大学 2025-05-27 CN disclosed
EP-4422707-A1 COLLAGEN-CONTAINING CURABLE FORMULATIONS CollPlant Ltd. (IL) 2024-09-04 EP disclosed
WO-2024059113-A1 MULTIPLE-COMPONENT COATING KIT AND METHOD OF USE THEREOF TO IMPART ANTI-ICING CHARACTERISTICS TO ARTICLES PHAZEBREAK COATINGS, INC. (US) 2024-03-21 WO disclosed
US-20240085670-A1 METHODS OF MAKING A LOW-COST MINIATURE ACCOMMODATING OPTICAL IMAGING SYSTEM NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2024-03-14 US disclosed
WO-2024015316-A1 COATED FLEXIBLE ARTICLES WITH ANTI-ICING SURFACE PHAZEBREAK COATINGS, INC. (US) 2024-01-18 WO disclosed
WO-2021144395-A1 CARBOXYLIC DITHIOCARBAMIC ACID ANHYDRIDE COMPOUNDS AND COMPOSITIONS THEREOF FUNDACIÓ INSTITUT CATALÀ D'INVESTIGACIÓ QUÍMICA (ICIQ) (ES) 2021-07-22 WO disclosed
US-20210009408-A1 3D PRINTER, RESIN, AND INTERCONNECT Woolley Adam (US) 2021-01-14 US disclosed
US-10597289-B1 3D printer, resin, and interconnect CREATIVE CADWORKS INC. (CA) 2020-03-24 US disclosed
EP-1829447-B1 AQUEOUS COMPOSITION FOR THE PROTECTION AND STRENGTHENING OF PLANTS AND APPLICATION METHOD THEREOF CT DE INVESTIGACION Y ASISTENCIA EN TECNOLOGIA Y DISENO DEL ESTADO DE JALISCO A C CIATEJ A C (MX) 2012-08-15 EP disclosed
US-8084396-B2 Polyethylene glycol, vitamin A, red coloring agent; preventing biotic or abiotic factors generating stress in plants Centro de Investigacion y Asistencia en Technologia y Diseno del Estado de Jalisco A.C. (MX) 2011-12-27 US disclosed
US-20080119360-A1 Aqueous Composition for the Protection and Strengthening of Plants and Application Method Thereof CENTRO DE INVESTIGACION Y ASISTENCIA (MX) 2008-05-22 US disclosed
EP-1829447-A1 AQUEOUS COMPOSITION FOR THE PROTECTION AND STRENGTHENING OF PLANTS AND APPLICATION METHOD THEREOF Centro de Investigacion y Asistencia en Technologa y Diseo del Estado de Jalisco, A.C. ( Ciatej, A.C.) (MX) 2007-09-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250295791-A1 COLLAGEN-CONTAINING CURABLE FORMULATIONS COL1A1, COL14A1, COL2A1 AMY1A 2809/4885PIM1 4590/4885CD38 1150/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.